Invention Grant
- Patent Title: Heterocyclic compound and use thereof
-
Application No.: US16052967Application Date: 2018-08-02
-
Publication No.: US10428023B2Publication Date: 2019-10-01
- Inventor: Yuichi Kajita , Yuhei Miyanohana , Tatsuki Koike , Kohei Takeuchi , Yoshiteru Ito , Norihito Tokunaga , Takahiro Sugimoto , Tohru Miyazaki , Tsuneo Oda , Yasutaka Hoashi , Yasushi Hattori , Keisuke Imamura
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2017-150685 20170803; JP2017-248495 20171225
- Main IPC: C07D211/56
- IPC: C07D211/56 ; A61P25/00 ; C07D205/04 ; C07D207/14 ; C07D401/06 ; C07D401/10 ; C07D401/14 ; C07D403/06 ; C07D405/10 ; C07D405/12 ; C07D413/06 ; C07D417/06 ; C07D417/14 ; C07D405/06 ; C07D211/36
Abstract:
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.
Public/Granted literature
- US20190040010A1 HETEROCYCLIC COMPOUND AND USE THEREOF Public/Granted day:2019-02-07
Information query
